Abeona Therapeutics Inc (ABEO)

SG&A Expense Growth

-15.02%

Quarterly · Period ending:

ABEO logo

ABEO SG&A Expense Growth

Latest reported-15.02%
ABEO Quarterly SG&A Growth (QoQ) (0.00% → -15.02%)
High-resolution chart · PNG

ABEO sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Abeona Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
6.1927%
-17.8908%
59.9398%
-31.8275%
26.1658%
45.1128%
-9.215%
-41.4%
30.5483%
-12.9545%
22.2222%
-16.2791%
-4.4444%
-61.8644%
162.2222%
0%
2.2727%
-43.5897%
59.1837%
13.9535%
-95.0518%
1,509.2593%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.